BNP PARIBAS FINANCIAL MARKETS - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 176 filers reported holding INSMED INC in Q2 2019. The put-call ratio across all filers is 1.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$3,109,664
+53.3%
123,155
+28.1%
0.00%
+33.3%
Q2 2023$2,028,448
-68.7%
96,135
-74.7%
0.00%
-66.7%
Q1 2023$6,472,095
-38.9%
379,595
-28.4%
0.01%
-43.8%
Q4 2022$10,593,816
-98.4%
530,221
+1500.3%
0.02%
+1500.0%
Q2 2022$653,383,000
-63.4%
33,133
-56.4%
0.00%
-50.0%
Q1 2022$1,783,932,000
-8.0%
75,912
+6.6%
0.00%
-33.3%
Q4 2021$1,939,325,000
+226.7%
71,194
+230.3%
0.00%
+200.0%
Q3 2021$593,625,000
-44.0%
21,555
-42.1%
0.00%0.0%
Q2 2021$1,059,452,000
+141.2%
37,226
+188.7%
0.00%0.0%
Q1 2021$439,204,000
-13.2%
12,895
-15.1%
0.00%0.0%
Q4 2020$505,775,000
-34.0%
15,193
-36.3%
0.00%0.0%
Q3 2020$766,250,000
+142.5%
23,841
+107.8%
0.00%0.0%
Q2 2020$315,966,000
-56.2%
11,473
-74.5%
0.00%0.0%
Q1 2020$720,677,000
+136.9%
44,958
+252.9%
0.00%0.0%
Q4 2019$304,207,000
-82.9%
12,739
-23.2%
0.00%
-66.7%
Q3 2019$1,776,912,000
+573.0%
16,582
+60.8%
0.00%
+200.0%
Q2 2019$264,013,000
-79.8%
10,313
-77.1%
0.00%
-66.7%
Q1 2019$1,306,609,000
+5321.4%
44,947
+2346.8%
0.00%
Q4 2018$24,101,000
-93.9%
1,837
-59.6%
0.00%
Q3 2018$392,126,000
+288.0%
4,543
+6.3%
0.00%
Q2 2018$101,056,000
-83.2%
4,273
-84.0%
0.00%
-100.0%
Q1 2018$602,252,000
+19.4%
26,743
+65.3%
0.00%0.0%
Q4 2017$504,586,000
+93.3%
16,183
+93.5%
0.00%0.0%
Q3 2017$261,072,000
+102.9%
8,365
+11.6%
0.00%
Q2 2017$128,666,000
+651.3%
7,498
+666.7%
0.00%
Q1 2017$17,125,000
-21.3%
978
-40.5%
0.00%
Q4 2016$21,750,000
-67.8%
1,644
-64.7%
0.00%
Q3 2016$67,562,000
+184.6%
4,653
+93.2%
0.00%
Q2 2016$23,743,000
-90.0%
2,408
-81.6%
0.00%
-100.0%
Q4 2015$237,474,000
+2.1%
13,084
+4.4%
0.00%0.0%
Q3 2015$232,664,000
+86.2%
12,529
+144.9%
0.00%
Q2 2015$124,933,000
+412.1%
5,116
+336.1%
0.00%
Q1 2015$24,398,000
-40.4%
1,173
-62.6%
0.00%
Q3 2014$40,925,000
+29342.4%
3,136
+31260.0%
0.00%
Q1 2014$139,000
-98.2%
10
-97.8%
0.00%
Q4 2013$7,633,000
-94.6%
449
-96.2%
0.00%
Q2 2013$141,989,00011,8720.00%
Other shareholders
INSMED INC shareholders Q2 2019
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,054,713$49,839,0003.76%
SENZAR ASSET MANAGEMENT, LLC 788,936$7,778,909,0001.70%
NEXTHERA CAPITAL LP 168,700$1,663,0001.44%
ACUTA CAPITAL PARTNERS, LLC 220,000$2,169,0001.04%
Orbimed Advisors 4,158,600$41,004,0000.43%
EMERALD MUTUAL FUND ADVISERS TRUST 667,848$6,585,0000.37%
Rock Springs Capital Management LP 497,500$4,905,0000.36%
EMERALD ADVISERS, LLC 630,159$6,213,0000.30%
Virtus ETF Advisers LLC 24,536$242,0000.18%
Baker Brothers Advisors 1,500,000$14,790,0000.16%
View complete list of INSMED INC shareholders